National Cancer Institute (NCI)

"Together, we will continue to make a difference." Dr. Kimryn Rathmell reflects on the contributions of the cancer community and the continuing work of cancer research. Read her message below. 👇 👇👇 Reflections and Hope: A message from Dr. Kimryn Rathmell to the cancer community When a community is affected by cancer—in even one member—the family, friends, neighbors, co-workers, and even acquaintances are often impacted. We rally support, we hug and we cry, and we redouble our collective efforts to advance the science that can prevent, detect, treat, or cure this set of diseases. As I reflect on what I have come to know about the cancer community, I am inspired and confident that this broad network of committed individuals will come together to produce outstanding advances for the benefit of so many, as they have so many times throughout history. Shouldering arm in arm—patients, scientists, care providers, students—to make the experience better for the patient today, and to make the expectations better for the patient of tomorrow. In the words of Dr. Monica Bertagnolli, who I had the distinct pleasure to work with during her term as NIH director, “NIH’s work is not finished when we deliver scientific discoveries; our work is finished when all people are living long and healthy lives.” This work will absolutely continue. Because we have an obligation to offer hope for people with cancer. Because we know that we must eliminate inequities so that all people can benefit. Because we have learned to effectively partner with patients and advocates. Because we have the knowledge and tools to accelerate progress. For these reasons and more, we redouble our collective efforts, at NCI and across the cancer community, to remind ourselves why cancer research matters and why we must continue to support cancer research.             As I move this afternoon from my role as NCI director back to private citizen championing innovation in medical science, equity in health care, commitment to mentorship, and reliance on engagement, communication, and partnership as means to build trust, I want to remind all of us that public support for cancer research matters. Public support and funding for cancer research is the cornerstone of our signature transformation in the trajectory of this set of diseases—as demonstrated just this week in the newly published Cancer Facts & Figures 2025—just one example of a unique partnership of federally and privately funded work, that showcases how accurate information informs science and policy. Together, we will continue to make a difference. - W. Kimryn Rathmell, MD, PhD   

The Molecular Characterization Initiative is part of NCI’s Childhood Cancer Data Initiative and is a national collaboration between the childhood cancer community, including the Children’s Oncology Group, advocates, pediatric oncologists, researchers, data scientists, children and adolescent and young adults (AYAs) with cancer, and families. It provides state-of-the-art molecular characterization at the time of diagnosis that helps participants and doctors select the best and most appropriate treatment. Participation in the initiative is voluntary and the costs to participate are covered by the program. Learn more: https://go.nih.gov/HRbI4au #AYASCM #Data4ChildhoodCancer

Want the latest updates on the National Cancer Plan? Subscribe to the National Cancer Plan Updates Newsletter and stay informed about news, activities, and collaborations across the cancer community. https://go.nih.gov/IjXSxSM

Dr. Alan Rein is an expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). In an interview conducted before his recent retirement, Dr. Rein reflected on his career at NCI and the future of the retroviral replication and pathogenesis field. https://go.nih.gov/bWjIyUQ Media Description: Dr. Alan Rein (left), with his mentor, the former director of Cold Spring Harbor Laboratory, Dr. Arthur Chovnick (right).

Dr. W. Kimryn Rathmell will step down as NCI Director, effective Monday, January 20. Read Dr. Rathmell’s thoughts in her announcement below.

The National Cancer Plan aims to maximize the utility of data through research and partnerships. Check out these stories about progress toward this goal: https://go.nih.gov/2u0CboO

New Episode of Inside Cancer Careers! 🎧 In celebration of National Mentoring Month, join us for an inspiring conversation about the power of mentorship in cancer research! This episode features Dr. Andrea Apolo, one of the 2025 NCI Outstanding Mentor Awardees, alongside her fellows who nominated her for this award, Dr. Saad Atiq and Dr. Andre Kydd. Tune in today: https://lnkd.in/eCXvjZ-x

Up to 40% of people being treated for cancer use cannabis to help with side effects like pain and anxiety. But with evidence from studies on cannabis lacking, clinicians feel ill-equipped to answer patient questions about its safety and effectiveness. https://go.nih.gov/sG3IxXP

Cervical cancer is highly preventable and highly curable if caught early. Nearly all cervical cancers could be prevented by HPV vaccination, routine #CervicalCancer screening, and appropriate follow-up treatment when needed. https://go.nih.gov/xgQ4iK5 Media Description: Cytological specimen showing cervical cancer specifically squamous cell carcinoma in the cervix.

Lack of appetite, or not feeling like eating, is a common problem caused by cancer and its treatment. Here are 10 ways to manage appetite loss that you can try. For more helpful hints, check out https://go.nih.gov/F5VKDFU